BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 12918149)

  • 1. [Correlation of the anatomo-pathological staging of radical prostatectomy specimens with the amount of cancer in the preoperative sextant biopsy].
    Ojea Calvo A; Núñez López A; Domínguez Freire F; Alonso Rodrigo A; Rodríguez Iglesias B; Benavente Delgado J; Barros Rodríguez JM; Gómez-González MC; González Piñeiro A; Otero García M; Nogueira March JL
    Actas Urol Esp; 2003 Jun; 27(6):428-37. PubMed ID: 12918149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The percent of cores positive for cancer in prostate needle biopsy specimens is strongly predictive of tumor stage and volume at radical prostatectomy.
    Sebo TJ; Bock BJ; Cheville JC; Lohse C; Wollan P; Zincke H
    J Urol; 2000 Jan; 163(1):174-8. PubMed ID: 10604340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of extraprostatic extension of prostate cancer based on needle biopsy findings: perineural invasion lacks significance on multivariate analysis.
    Egan AJ; Bostwick DG
    Am J Surg Pathol; 1997 Dec; 21(12):1496-500. PubMed ID: 9414194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical, Pathological and Oncologic Findings of Radical Prostatectomy with Extraprostatic Extension Diagnosed on Preoperative Prostate Biopsy.
    Faisal FA; Tosoian JJ; Han M; Macura KJ; Pavlovich CP; Lotan TL
    J Urol; 2019 May; 201(5):937-942. PubMed ID: 30414957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting prostate carcinoma volume and stage at radical prostatectomy by assessing needle biopsy specimens for percent surface area and cores positive for carcinoma, perineural invasion, Gleason score, DNA ploidy and proliferation, and preoperative serum prostate specific antigen: a report of 454 cases.
    Sebo TJ; Cheville JC; Riehle DL; Lohse CM; Pankratz VS; Myers RP; Blute ML; Zincke H
    Cancer; 2001 Jun; 91(11):2196-204. PubMed ID: 11391602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The extent of biopsy involvement as an independent predictor of extraprostatic extension and surgical margin status in low risk prostate cancer: implications for treatment selection.
    Gao X; Mohideen N; Flanigan RC; Waters WB; Wojcik EM; Leman CR
    J Urol; 2000 Dec; 164(6):1982-6. PubMed ID: 11061896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Percent prostate needle biopsy tissue with cancer is more predictive of biochemical failure or adverse pathology after radical prostatectomy than prostate specific antigen or Gleason score.
    Freedland SJ; Csathy GS; Dorey F; Aronson WJ
    J Urol; 2002 Feb; 167(2 Pt 1):516-20. PubMed ID: 11792909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multivariate models to predict clinically important outcomes at prostatectomy for patients with organ-confined disease and needle biopsy Gleason scores of 6 or less.
    DiMarco DS; Blute ML; Zincke H; Cheville JC; Riehle DL; Lohse CM; Pankratz VS; Sebo TJ
    Urol Oncol; 2003; 21(6):439-46. PubMed ID: 14693270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perineural invasion in prostate needle biopsy specimens. Correlation with extraprostatic extension at resection.
    Vargas SO; Jiroutek M; Welch WR; Nucci MR; D'Amico AV; Renshaw AA
    Am J Clin Pathol; 1999 Feb; 111(2):223-8. PubMed ID: 9930144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenocarcinoma of the prostate with Gleason score 9-10 on core biopsy: correlation with findings at radical prostatectomy and prognosis.
    Ellis CL; Partin AW; Han M; Epstein JI
    J Urol; 2013 Dec; 190(6):2068-73. PubMed ID: 23727307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of tumour volume and pathological stage in radical prostatectomy specimens is not improved by taking more prostate needle-biopsy cores.
    Grossklaus DJ; Coffey CS; Shappell SB; Jack GS; Cookson MS
    BJU Int; 2001 Nov; 88(7):722-6. PubMed ID: 11890243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ability of sextant biopsies to predict radical prostatectomy stage.
    Wills ML; Sauvageot J; Partin AW; Gurganus R; Epstein JI
    Urology; 1998 May; 51(5):759-64. PubMed ID: 9610589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Important preoperative prognostic factors for extracapsular extension, seminal vesicle invasion and lymph node involvement in cases with radical retropubic prostatectomy.
    Ozgür A; Onol FF; Türkeri LN
    Int Urol Nephrol; 2004; 36(3):369-73. PubMed ID: 15783108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of the percentage of prostate needle biopsy cores with cancer as a predictor of disease extension in radical prostatectomy specimens in Japanese men.
    Sakai I; Harada K; Hara I; Eto H; Miyake H
    Int Urol Nephrol; 2005; 37(2):305-10. PubMed ID: 16142561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of extraprostatic cancer by prostate specific antigen density, endorectal MRI, and biopsy Gleason score in clinically localized prostate cancer.
    Horiguchi A; Nakashima J; Horiguchi Y; Nakagawa K; Oya M; Ohigashi T; Marumo K; Murai M
    Prostate; 2003 Jun; 56(1):23-9. PubMed ID: 12746843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gleason score 7 prostate cancer on needle biopsy: is the prognostic difference in Gleason scores 4 + 3 and 3 + 4 independent of the number of involved cores?
    Makarov DV; Sanderson H; Partin AW; Epstein JI
    J Urol; 2002 Jun; 167(6):2440-2. PubMed ID: 11992053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple measures of carcinoma extent versus perineural invasion in prostate needle biopsy tissue in prediction of pathologic stage in a screening population.
    Bismar TA; Lewis JS; Vollmer RT; Humphrey PA
    Am J Surg Pathol; 2003 Apr; 27(4):432-40. PubMed ID: 12657927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Percent of prostate needle biopsy cores with cancer is significant independent predictor of prostate specific antigen recurrence following radical prostatectomy: results from SEARCH database.
    Freedland SJ; Aronson WJ; Terris MK; Kane CJ; Amling CL; Dorey F; Presti JC;
    J Urol; 2003 Jun; 169(6):2136-41. PubMed ID: 12771735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percent of cancer in the biopsy set predicts pathological findings after prostatectomy.
    Grossklaus DJ; Coffey CS; Shappell SB; Jack GS; Chang SS; Cookson MS
    J Urol; 2002 May; 167(5):2032-5; discussion 2036. PubMed ID: 11956432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of pathological stages before prostatectomy in prostate cancer patients: analysis of 12 systematic prostate needle biopsy specimens.
    Park EA; Lee HJ; Kim KG; Kim SH; Lee SE; Choe GY
    Int J Urol; 2007 Aug; 14(8):704-8. PubMed ID: 17681059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.